Camlin Fine Sciences Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹159.6
- Today's High:
- ₹176.6
- Open Price:
- ₹175.5
- 52W Low:
- ₹111.65
- 52W High:
- ₹186.25
- Prev. Close:
- ₹174.95
- Volume:
- 1816802
Company Statistics
- Market Cap.:
- ₹28.80 billion
- Book Value:
- 52.158
- Revenue TTM:
- ₹17.17 billion
- Operating Margin TTM:
- 8.4%
- Gross Profit TTM:
- ₹8.37 billion
- Profit Margin:
- 3.6%
- Return on Assets TTM:
- 4.96%
- Return on Equity TTM:
- 5.01%
Company Profile
Camlin Fine Sciences Limited had its IPO on under the ticker symbol CAMLINFINE.
The company operates in the Basic Materials sector and Specialty Chemicals industry. Camlin Fine Sciences Limited has a staff strength of 627 employees.
Stock update
Shares of Camlin Fine Sciences Limited opened at ₹175.5 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹159.6 - ₹176.6, and closed at ₹160.5.
This is a -8.26% slip from the previous day's closing price.
A total volume of 1,816,802 shares were traded at the close of the day’s session.
In the last one week, shares of Camlin Fine Sciences Limited have slipped by -7.63%.
Camlin Fine Sciences Limited's Key Ratios
Camlin Fine Sciences Limited has a market cap of ₹28.80 billion, indicating a price to book ratio of 3.0882 and a price to sales ratio of 1.315.
In the last 12-months Camlin Fine Sciences Limited’s revenue was ₹17.17 billion with a gross profit of ₹8.37 billion and an EBITDA of ₹2.00 billion. The EBITDA ratio measures Camlin Fine Sciences Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Camlin Fine Sciences Limited’s operating margin was 8.4% while its return on assets stood at 4.96% with a return of equity of 5.01%.
In Q2, Camlin Fine Sciences Limited’s quarterly earnings growth was a positive 154.1% while revenue growth was a positive 9.3%.
Camlin Fine Sciences Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 44.0153
- PEG
Its diluted EPS in the last 12-months stands at ₹3.91 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Camlin Fine Sciences Limited’s profitability.
Camlin Fine Sciences Limited stock is trading at a EV to sales ratio of 1.8143 and a EV to EBITDA ratio of 15.6977. Its price to sales ratio in the trailing 12-months stood at 1.315.
Camlin Fine Sciences Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹20.60 billion
- Total Liabilities
- ₹7.93 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Camlin Fine Sciences Limited ended 2024 with ₹20.60 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹20.60 billion while shareholder equity stood at ₹8.19 billion.
Camlin Fine Sciences Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹7.93 billion in other current liabilities, in common stock, ₹3.03 billion in retained earnings and ₹527.93 million in goodwill. Its cash balance stood at ₹937.42 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹4.08 billion.
Camlin Fine Sciences Limited’s total current assets stands at ₹10.88 billion while long-term investments were ₹0 and short-term investments were ₹96.26 million. Its net receivables were ₹3.05 billion compared to accounts payable of ₹2.88 billion and inventory worth ₹5.68 billion.
In 2024, Camlin Fine Sciences Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Camlin Fine Sciences Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹160.5
- 52-Week High
- ₹186.25
- 52-Week Low
- ₹111.65
- Analyst Target Price
- ₹
Camlin Fine Sciences Limited stock is currently trading at ₹160.5 per share. It touched a 52-week high of ₹186.25 and a 52-week low of ₹186.25. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹159.96 and 200-day moving average was ₹156.87 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4872.7% of the company’s stock are held by insiders while 1074.1% are held by institutions.
Frequently Asked Questions About Camlin Fine Sciences Limited
Similar Industry Stocks (Specialty Chemicals)
Most Active
Top Gainers
Top Losers
About
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; pharmaceutical and nutraceutical products from fermentation and plant extraction sources; and performance chemicals, such as hydroquinone and catechol. Its products are used in food and beverage, pet food and animal nutrition, rendering, aqua culture, petrochemical, pharmaceutical, agrochemical, dyes and pigment, biofuel, aroma technical, fragrance, and flavor industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.